Literature DB >> 24891985

AMP-activated Protein Kinase (AMPK): Does This Master Regulator of Cellular Energy State Distinguish Insulin Sensitive from Insulin Resistant Obesity?

X Julia Xu1, Rudy J Valentine1, Neil B Ruderman1.   

Abstract

Although a correlation exists between obesity and insulin resistance, roughly 25 % of obese individuals are insulin sensitive. AMP-activated protein kinase (AMPK) is a cellular energy sensor that among its many actions, integrates diverse physiological signals to restore energy balance. In addition, in many situations it also increases insulin sensitivity. In this context, AMPK activity is decreased in very obese individuals undergoing bariatric surgery who are insulin resistant compared to equally obese patients who are insulin sensitive. In this review, we will both explore what distinguishes these individuals, and evaluate the evidence that diminished AMPK is associated with insulin resistance and metabolic syndrome-associated disorders in other circumstances.

Entities:  

Keywords:  AMPK; Bariatric surgery; Fetuin-A; Insulin resistant; Insulin sensitive; Obesity

Year:  2014        PMID: 24891985      PMCID: PMC4039173          DOI: 10.1007/s13679-014-0095-x

Source DB:  PubMed          Journal:  Curr Obes Rep        ISSN: 2162-4968


  115 in total

1.  p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake.

Authors:  Yossi Dagon; Elizabeth Hur; Bin Zheng; Kerry Wellenstein; Lewis C Cantley; Barbara B Kahn
Journal:  Cell Metab       Date:  2012-06-21       Impact factor: 27.287

Review 2.  Insulin-sensitive obesity in humans - a 'favorable fat' phenotype?

Authors:  D Samocha-Bonet; D J Chisholm; K Tonks; L V Campbell; J R Greenfield
Journal:  Trends Endocrinol Metab       Date:  2012-01-26       Impact factor: 12.015

Review 3.  Cardiovascular and metabolic effects of obesity.

Authors:  Margaret J Morris
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-04       Impact factor: 2.557

4.  Liver AMP-activated protein kinase and acetyl-CoA carboxylase during and after exercise.

Authors:  C L Carlson; W W Winder
Journal:  J Appl Physiol (1985)       Date:  1999-02

5.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

6.  Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

Authors:  Alisan Kahraman; Jan-Peter Sowa; Martin Schlattjan; Svenja Sydor; Martin Pronadl; Alexander Wree; Anja Beilfuss; Alpaslan Kilicarslan; Akif Altinbaş; Lars Peter Bechmann; Wing-Kin Syn; Guido Gerken; Ali Canbay
Journal:  Clin Sci (Lond)       Date:  2013-10       Impact factor: 6.124

7.  Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.

Authors:  R Bergeron; S F Previs; G W Cline; P Perret; R R Russell; L H Young; G I Shulman
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

8.  Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss.

Authors:  Johanna Maria Brix; Harald Stingl; Florian Höllerl; Gerit Holger Schernthaner; Hans-Peter Kopp; Guntram Schernthaner
Journal:  J Clin Endocrinol Metab       Date:  2010-07-21       Impact factor: 5.958

9.  Fetuin-A and change in body composition in older persons.

Authors:  Joachim H Ix; Christina L Wassel; Glenn M Chertow; Annemarie Koster; Karen C Johnson; Frances A Tylavsky; Jane A Cauley; Steven R Cummings; Tamara B Harris; Michael G Shlipak
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  7 in total

Review 1.  Fetuin-A: a novel link between obesity and related complications.

Authors:  J F Trepanowski; J Mey; K A Varady
Journal:  Int J Obes (Lond)       Date:  2014-12-03       Impact factor: 5.095

2.  TallyHO obese female mice experience poor reproductive outcomes and abnormal blastocyst metabolism that is reversed by metformin.

Authors:  Erica D Louden; Kerri M Luzzo; Patricia T Jimenez; Tiffany Chi; Maggie Chi; Kelle H Moley
Journal:  Reprod Fertil Dev       Date:  2014-12       Impact factor: 2.311

3.  Insulin inhibits AMPK activity and phosphorylates AMPK Ser⁴⁸⁵/⁴⁹¹ through Akt in hepatocytes, myotubes and incubated rat skeletal muscle.

Authors:  Rudy J Valentine; Kimberly A Coughlan; Neil B Ruderman; Asish K Saha
Journal:  Arch Biochem Biophys       Date:  2014-08-27       Impact factor: 4.013

Review 4.  Increased Use of Emulsifiers in Processed Foods and the Links to Obesity.

Authors:  Janese Laster; Sara L Bonnes; Jason Rocha
Journal:  Curr Gastroenterol Rep       Date:  2019-12-02

5.  Skeletal muscle O-GlcNAc transferase is important for muscle energy homeostasis and whole-body insulin sensitivity.

Authors:  Hao Shi; Alexander Munk; Thomas S Nielsen; Morgan R Daughtry; Louise Larsson; Shize Li; Kasper F Høyer; Hannah W Geisler; Karolina Sulek; Rasmus Kjøbsted; Taylor Fisher; Marianne M Andersen; Zhengxing Shen; Ulrik K Hansen; Eric M England; Zhiyong Cheng; Kurt Højlund; Jørgen F P Wojtaszewski; Xiaoyong Yang; Matthew W Hulver; Richard F Helm; Jonas T Treebak; David E Gerrard
Journal:  Mol Metab       Date:  2018-02-24       Impact factor: 7.422

Review 6.  Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs.

Authors:  Milton Packer
Journal:  Cardiovasc Diabetol       Date:  2020-05-13       Impact factor: 9.951

7.  Veratrilla baillonii Franch Ameliorates Diabetic Liver Injury by Alleviating Insulin Resistance in Rats.

Authors:  Zhi-Hao Zhang; Juan Li; Jun Li; Zhaowu Ma; Xian-Ju Huang
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.